Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome

Abstract Background Despite strong antiplatelet therapy with ticagrelor, serious ischemic events still occur in patients with acute coronary syndrome (ACS). The predictability of platelet reactivity to the residual risk of ischemic events during ticagrelor treatment remains uncertain. Objectives We...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuting Zou, Yuyan Wang, Yangxun Wu, Shizhao Zhang, Haiping Liu, Tong Yin
Format: Artigo
Language:Inglês
Published: BMC 2022-04-01
Series:Thrombosis Journal
Subjects:
Ticagrelor
Platelet inhibition rate
Thromboelastography
Acute coronary syndrome
Online Access:https://doi.org/10.1186/s12959-022-00380-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items